Global Optic Nerve Glioma 麻豆原创 Research Report 2023

Publication ID:

PB502233993

Publication Date:

February 7, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

An optic nerve glioma is a type of brain tumor. There are multiple kinds of brain tumors. Typically, each type of tumor is named after the kinds of cells it affects. Most optic nerve gliomas are considered low-grade and don鈥檛 grow as quickly as other types of brain tumors. They are found in the optic chiasm, where the left and right optic nerves cross. They are also referred to as optic glioma or juvenile pilocytic astrocytoma. Optic nerve glioma is a rare kind of cancer that鈥檚 typically slow growing and found in children. It is rarely found in individuals over the age of 20. It has also been associated with the genetic disorder neurofibromatosis type 1, or NF1.
Highlights
The global Optic Nerve Glioma market was valued at US$ 336.3 million in 2022 and is anticipated to reach US$ 392.2 million by 2029, witnessing a CAGR of 2.6% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Treatment for these cancers is best done by a multidisciplinary treatment team. Surgery and radiation therapy are two possible ways of treating optic nerve glioma. Surgery may be performed if doctors believe they can use it to completely remove the tumor. Alternately, if the tumor is not completely removable, surgeons may remove parts of it to help relieve pressure in the skull. Radiation therapy can be done before surgery to shrink the tumor before doctors it. Alternately, it may be done after surgery to kill any remaining cancer cells. Radiation therapy involves using a machine to aim high-energy rays at the site of the tumor. Chemotherapy uses medications to kill cancer cells. This is particularly useful if the cancer has spread to other parts of the brain. Corticosteroids may be administered to reduce swelling in the skull.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Optic Nerve Glioma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Optic Nerve Glioma.
The Optic Nerve Glioma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Optic Nerve Glioma market comprehensively. Regional market sizes, concerning products by diagnosis, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Optic Nerve Glioma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by diagnosis, by application, and by regions.
By Company
Biocompare
Bio-Rad Laboratories
Miltenyi Biotec
BioLegend
Becton, Dickinson And Company
Beckman Coulter
Merck
ImmunoReagents
Thermo Fisher Scientific
Segment by Diagnosis
Neurological Exam
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Biopsy
Segment by Application
Hospitals & Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by diagnosis, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Optic Nerve Glioma companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by diagnosis, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Diagnosis
1.2.1 Global Optic Nerve Glioma 麻豆原创 Size Growth Rate by Diagnosis: 2018 VS 2022 VS 2029
1.2.2 Neurological Exam
1.2.3 Computed Tomography (CT)
1.2.4 Magnetic Resonance Imaging (MRI)
1.2.5 Biopsy
1.3 麻豆原创 by Application
1.3.1 Global Optic Nerve Glioma 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals & Clinics
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Optic Nerve Glioma 麻豆原创 Perspective (2018-2029)
2.2 Optic Nerve Glioma Growth Trends by Region
2.2.1 Global Optic Nerve Glioma 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Optic Nerve Glioma Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Optic Nerve Glioma Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Optic Nerve Glioma 麻豆原创 Dynamics
2.3.1 Optic Nerve Glioma Industry Trends
2.3.2 Optic Nerve Glioma 麻豆原创 Drivers
2.3.3 Optic Nerve Glioma 麻豆原创 Challenges
2.3.4 Optic Nerve Glioma 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Optic Nerve Glioma Players by Revenue
3.1.1 Global Top Optic Nerve Glioma Players by Revenue (2018-2023)
3.1.2 Global Optic Nerve Glioma Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Optic Nerve Glioma 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Optic Nerve Glioma Revenue
3.4 Global Optic Nerve Glioma 麻豆原创 Concentration Ratio
3.4.1 Global Optic Nerve Glioma 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Optic Nerve Glioma Revenue in 2022
3.5 Optic Nerve Glioma Key Players Head office and Area Served
3.6 Key Players Optic Nerve Glioma Product Solution and Service
3.7 Date of Enter into Optic Nerve Glioma 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Optic Nerve Glioma Breakdown Data by Diagnosis
4.1 Global Optic Nerve Glioma Historic 麻豆原创 Size by Diagnosis (2018-2023)
4.2 Global Optic Nerve Glioma Forecasted 麻豆原创 Size by Diagnosis (2024-2029)
5 Optic Nerve Glioma Breakdown Data by Application
5.1 Global Optic Nerve Glioma Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Optic Nerve Glioma Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Optic Nerve Glioma 麻豆原创 Size (2018-2029)
6.2 North America Optic Nerve Glioma 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Optic Nerve Glioma 麻豆原创 Size by Country (2018-2023)
6.4 North America Optic Nerve Glioma 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Optic Nerve Glioma 麻豆原创 Size (2018-2029)
7.2 Europe Optic Nerve Glioma 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Optic Nerve Glioma 麻豆原创 Size by Country (2018-2023)
7.4 Europe Optic Nerve Glioma 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Optic Nerve Glioma 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Optic Nerve Glioma 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Optic Nerve Glioma 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Optic Nerve Glioma 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Optic Nerve Glioma 麻豆原创 Size (2018-2029)
9.2 Latin America Optic Nerve Glioma 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Optic Nerve Glioma 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Optic Nerve Glioma 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Optic Nerve Glioma 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Optic Nerve Glioma 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Optic Nerve Glioma 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Optic Nerve Glioma 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocompare
11.1.1 Biocompare Company Detail
11.1.2 Biocompare Business Overview
11.1.3 Biocompare Optic Nerve Glioma Introduction
11.1.4 Biocompare Revenue in Optic Nerve Glioma Business (2018-2023)
11.1.5 Biocompare Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Optic Nerve Glioma Introduction
11.2.4 Bio-Rad Laboratories Revenue in Optic Nerve Glioma Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Miltenyi Biotec
11.3.1 Miltenyi Biotec Company Detail
11.3.2 Miltenyi Biotec Business Overview
11.3.3 Miltenyi Biotec Optic Nerve Glioma Introduction
11.3.4 Miltenyi Biotec Revenue in Optic Nerve Glioma Business (2018-2023)
11.3.5 Miltenyi Biotec Recent Development
11.4 BioLegend
11.4.1 BioLegend Company Detail
11.4.2 BioLegend Business Overview
11.4.3 BioLegend Optic Nerve Glioma Introduction
11.4.4 BioLegend Revenue in Optic Nerve Glioma Business (2018-2023)
11.4.5 BioLegend Recent Development
11.5 Becton, Dickinson And Company
11.5.1 Becton, Dickinson And Company Company Detail
11.5.2 Becton, Dickinson And Company Business Overview
11.5.3 Becton, Dickinson And Company Optic Nerve Glioma Introduction
11.5.4 Becton, Dickinson And Company Revenue in Optic Nerve Glioma Business (2018-2023)
11.5.5 Becton, Dickinson And Company Recent Development
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Detail
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Optic Nerve Glioma Introduction
11.6.4 Beckman Coulter Revenue in Optic Nerve Glioma Business (2018-2023)
11.6.5 Beckman Coulter Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Optic Nerve Glioma Introduction
11.7.4 Merck Revenue in Optic Nerve Glioma Business (2018-2023)
11.7.5 Merck Recent Development
11.8 ImmunoReagents
11.8.1 ImmunoReagents Company Detail
11.8.2 ImmunoReagents Business Overview
11.8.3 ImmunoReagents Optic Nerve Glioma Introduction
11.8.4 ImmunoReagents Revenue in Optic Nerve Glioma Business (2018-2023)
11.8.5 ImmunoReagents Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Detail
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Optic Nerve Glioma Introduction
11.9.4 Thermo Fisher Scientific Revenue in Optic Nerve Glioma Business (2018-2023)
11.9.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Biocompare
Bio-Rad Laboratories
Miltenyi Biotec
BioLegend
Becton, Dickinson And Company
Beckman Coulter
Merck
ImmunoReagents
Thermo Fisher Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.